Search Results | NIH

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Search Results 2521 – 2540 of 3231

Adverse Effects of Antiretroviral Medications

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/adverse-effects-antiretroviral-medications

Nephrotoxic Effects

https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/nephrotoxic-effects

Enfuvirtide (Fuzeon, T-20)

https://clinicalinfo.hiv.gov/guidelines/perinatal/archived-drugs-enfuvritide-fuzeon

https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/stavudine

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/malaria

Candida Infections

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/candida-infections

Candidiasis (Mucocutaneous)

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/candidiasis

Varicella-Zoster Virus Disease

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/varicella-zoster

https://clinicalinfo.hiv.gov/guidelines/perinatal/panel-roster

Postpartum HIV Management and Follow-Up

https://clinicalinfo.hiv.gov/guidelines/perinatal/postpartum-management-follow-up

Community-Acquired Bacterial Pneumonia

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/community-acquired

Laboratory Testing: Co-Receptor Tropism Assays

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/co-receptor-tropism-assays

Appendix D: Review of Clinical Trials of Antiretroviral Interventions to Prevent Perinatal HIV Transmission

https://clinicalinfo.hiv.gov/guidelines/perinatal/review-clinical-trials-arv-interventions-prevent-hiv-transmission

Hepatitis B Virus/HIV Coinfection

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/coinfections-hepatitis-b-virus-hiv

https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/overview-0

Special Populations: HIV and the Older Person

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/special-populations-hiv-and-older-person

Rash and Hypersensitivity Reactions

https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/rash-and-hypersensitivity-reactions

Overview: Drug-Drug Interactions between Antiretrovirals and Other Drugs

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/drug-interactions-overview

Bictegravir (BIC)

https://clinicalinfo.hiv.gov/guidelines/perinatal/safety-toxicity-arv-agents-integrase-inhibitors-bictegravir

Hepatitis C Virus

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/hepatitis-c-virus